Metrizamide--a potential in vivo inhibitor of glucose metabolism.
- 1 April 1983
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 147 (1) , 119-121
- https://doi.org/10.1148/radiology.147.1.6828715
Abstract
Metrizamide used as a contrast medium for examination of the subarachnoid space and its contents may produce adverse reactions, but the mechanism for these reactions is not certain. The present study demonstrated a depression of glucose metabolism in rat neural tissue by metrizamide. Paired experiments (16) using hippocampal tissue from rats showed a depression of glucose metabolism of 24.4 .+-. 4.78%. This depression was significant (P < 0.001) and was not related to a dilutional or hypertonic effect. The depression occurred at about the same time that adverse reactions were seen in patients, suggesting that the adverse reactions may be related to inhibition of glucose metabolism in the CNS.This publication has 3 references indexed in Scilit:
- Giant Synaptic Potential Hypothesis for Epileptiform ActivityScience, 1981
- Metrizamide—CSF Contrast MediumRadiology, 1977
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977